These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3519324)

  • 1. Controlled release of insulin from polymer matrices. Control of diabetes in rats.
    Brown L; Munoz C; Siemer L; Edelman E; Langer R
    Diabetes; 1986 Jun; 35(6):692-7. PubMed ID: 3519324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One month of sustained release of insulin from a polymer implant.
    Creque HM; Langer R; Folkman J
    Diabetes; 1980 Jan; 29(1):37-40. PubMed ID: 6991315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetically enhanced insulin release in diabetic rats.
    Kost J; Wolfrum J; Langer R
    J Biomed Mater Res; 1987 Dec; 21(12):1367-73. PubMed ID: 3323204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow release of insulin from a biodegradable matrix implanted in diabetic rats.
    Goosen MF; Leung YF; O'Shea GM; Chou S; Sun AM
    Diabetes; 1983 May; 32(5):478-81. PubMed ID: 6341132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of insulin from polymer matrices. In vitro kinetics.
    Brown L; Siemer L; Munoz C; Langer R
    Diabetes; 1986 Jun; 35(6):684-91. PubMed ID: 3519323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged release of insulin by cholesterol-matrix implant.
    Wang PY
    Diabetes; 1987 Sep; 36(9):1068-72. PubMed ID: 3301475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External control of drug release: controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats.
    Miyazaki S; Yokouchi C; Takada M
    J Pharm Pharmacol; 1988 Oct; 40(10):716-7. PubMed ID: 2907539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin treatment on long-term diabetes-induced alteration of myocardial function.
    Tahiliani AG; Lopaschuk GD; McNeill JH
    Gen Pharmacol; 1984; 15(6):545-7. PubMed ID: 6396159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.
    Fujimori Y; Katsuno K; Ojima K; Nakashima I; Nakano S; Ishikawa-Takemura Y; Kusama H; Isaji M
    Eur J Pharmacol; 2009 May; 609(1-3):148-54. PubMed ID: 19281809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of insulin release from implantable polymer-based delivery systems and augmentation of therapeutic effect with simultaneous release of somatostatin.
    Edelman ER; Brown L; Langer R
    J Pharm Sci; 1996 Dec; 85(12):1271-5. PubMed ID: 8961137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of somatomedin-like activity by serum from streptozotocin-diabetic rats: prevention by insulin treatment and correlation with skeletal growth.
    Taylor AM; Sharma AK; Avasthy N; Duguid IG; Blanchard DS; Thomas PK; Dandona P
    Endocrinology; 1987 Oct; 121(4):1360-5. PubMed ID: 2958269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatically controlled drug delivery.
    Fischel-Ghodsian F; Brown L; Mathiowitz E; Brandenburg D; Langer R
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2403-6. PubMed ID: 3281165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin controlled-release microcapsules to prolong the hypoglycemic effect in diabetic rats.
    Lin SY; Ho LT; Chiou HL
    Biomater Artif Cells Artif Organs; 1988; 16(4):815-28. PubMed ID: 3064829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative weight of glucose, insulin and parathyroid hormone in the urinary loss of phosphate by chronically diabetic rats.
    Locatto ME; Di Loreto V; Fernández MC; Caferra D; Puche RC
    Acta Diabetol; 1997 Oct; 34(3):211-6. PubMed ID: 9401643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    Kirilmaz OB; Salegaonkar AR; Shiau J; Uzun G; Ko HS; Lee HF; Park S; Kwon G
    PLoS One; 2021; 16(7):e0254718. PubMed ID: 34270619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of insulin from a hydrophilic polymer matrix implanted in diabetic rats.
    Miyazaki S; Yokouchi C; Takada M
    Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3689-91. PubMed ID: 3071428
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats.
    Ramesh B; Pugalendi KV
    J Med Food; 2006; 9(4):562-6. PubMed ID: 17201645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    Luippold G; Bedenik J; Voigt A; Grempler R
    PLoS One; 2016; 11(6):e0156346. PubMed ID: 27253523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus.
    Luippold G; Klein T; Mark M; Grempler R
    Diabetes Obes Metab; 2012 Jul; 14(7):601-7. PubMed ID: 22268612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma leptin in diabetic and insulin-treated diabetic and normal rats.
    Sivitz WI; Walsh S; Morgan D; Donohoue P; Haynes W; Leibel RL
    Metabolism; 1998 May; 47(5):584-91. PubMed ID: 9591751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.